Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 53


Bim regulates BCR-induced entry of B cells into the cell cycle.

Craxton A, Draves KE, Clark EA.

Eur J Immunol. 2007 Oct;37(10):2715-22.


Bim expression is reduced in human cutaneous melanomas.

Dai DL, Wang Y, Liu M, Martinka M, Li G.

J Invest Dermatol. 2008 Feb;128(2):403-7. Epub 2007 Jul 19.


Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.

Zantl N, Weirich G, Zall H, Seiffert BM, Fischer SF, Kirschnek S, Hartmann C, Fritsch RM, Gillissen B, Daniel PT, Häcker G.

Oncogene. 2007 Oct 25;26(49):7038-48. Epub 2007 May 7.


Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD.

Blood. 2007 Jul 15;110(2):695-708. Epub 2007 Mar 27.


Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.

Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Wacholder S, Chanock SJ, Habermann TM, Hartge P.

Blood. 2007 Jun 15;109(12):5439-46. Epub 2007 Feb 27.


Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L, Boffetta P, Cerhan JR, Maynadie M, Spinelli JJ, Chiu BC, Cocco PL, Mensah F, Zhang Y, Nieters A, Dal Maso L, Bracci PM, Costantini AS, Vineis P, Severson RK, Roman E, Cozen W, Weisenburger D, Davis S, Franceschi S, La Vecchia C, Foretova L, Becker N, Staines A, Vornanen M, Zheng T, Hartge P.

Blood. 2007 Apr 15;109(8):3479-88. Epub 2006 Dec 21.


Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.

Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK.

Carcinogenesis. 2007 Mar;28(3):704-12. Epub 2006 Oct 20.


Molecular pathways in follicular lymphoma.

Bende RJ, Smit LA, van Noesel CJ.

Leukemia. 2007 Jan;21(1):18-29. Epub 2006 Oct 12. Review.


Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.

Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, Severson RK, Chatterjee N, Yeager M, Chanock SJ, Rothman N.

Cancer Res. 2006 Oct 1;66(19):9771-80.


The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.

Jardin F, Ruminy P, Bastard C, Tilly H.

Pathol Biol (Paris). 2007 Feb;55(1):73-83. Epub 2006 Jul 3. Review.


Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.

Wang SS, Cozen W, Severson RK, Hartge P, Cerhan JR, Davis S, Welch R, Rothman N, Chanock SJ.

Hum Genet. 2006 Sep;120(2):297-300. Epub 2006 Jun 17.


Resampling-based multiple hypothesis testing procedures for genetic case-control association studies.

Chen BE, Sakoda LC, Hsing AW, Rosenberg PS.

Genet Epidemiol. 2006 Sep;30(6):495-507.


Cyclin D1: polymorphism, aberrant splicing and cancer risk.

Knudsen KE, Diehl JA, Haiman CA, Knudsen ES.

Oncogene. 2006 Mar 13;25(11):1620-8. Review.


Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S.

Blood. 2006 May 15;107(10):4101-8. Epub 2006 Jan 31.


Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A.

Lancet Oncol. 2006 Jan;7(1):27-38.


SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes.

Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, Sicotte H, Staats B, Acharya M, Crenshaw A, Eckert A, Puri V, Gerhard DS, Chanock SJ.

Nucleic Acids Res. 2006 Jan 1;34(Database issue):D617-21.


A tail strength measure for assessing the overall univariate significance in a dataset.

Taylor J, Tibshirani R.

Biostatistics. 2006 Apr;7(2):167-81. Epub 2005 Dec 6.


A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma.

Zhang Y, Lan Q, Rothman N, Zhu Y, Zahm SH, Wang SS, Holford TR, Leaderer B, Boyle P, Zhang B, Zou K, Chanock S, Zheng T.

J Natl Cancer Inst. 2005 Nov 2;97(21):1616-8.


Genetic variation and willingness to participate in epidemiologic research: data from three studies.

Bhatti P, Sigurdson AJ, Wang SS, Chen J, Rothman N, Hartge P, Bergen AW, Landi MT.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2449-53.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk